AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity

RecruitingNAAges 50 Years - 80 YearsAllRennes University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of the NODAL clinical trial is to demonstrate the feasibility of new, low-cost, non-invasive biomarkers of neurodegenerative pathologies as early Alzheimer and Parkinson, based on the estimation of the multimodal connectome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * For all participants: * French mother tongue * right-handed * with a level of education equal to or higher than the Certificat d'ร‰tudes Primaires (Primary School Certificate) * Free of any medical or psychiatric condition likely to interfere with cognition (excluding diagnosis for patients) * Affiliated with a social security scheme * Having received oral and written information about the protocol and having signed a consent form to participate in this research. DCS+ group: \- Meeting the diagnostic criteria for "subjective cognitive decline-plus" (Jessen criteria (Jessen et al., 2014). Alzheimer's patients "Mild Cognitive Impairment due to Alzheimer's Disease," "MCI-MA": \- Meeting the diagnostic criteria for "Mild neurocognitive disorder due to Alzheimer's disease" (criteria of (Albert et al., 2011)) De novo" Parkinsonian patients, "MPdn": \- Presenting with newly diagnosed ("de novo") Parkinson's disease and free of cognitive deficits (criteria of Postuma et al., 2015 (Postuma et al., 2015)) Parkinsonian patients with "Mild Cognitive Impairment, "MCI-MP": \- Presenting Parkinson's disease associated with "mild neurocognitive impairment" (criteria of Litvan et al., 2012 (Litvan et al., 2012)) Exclusion Criteria: * All participants (healthy volunteers and patients) * Contraindications to MRI : * Abdominal circumference + upper limbs sticking to the body \> 200 cm; * Implantable pacemaker or defibrillator; * Neurosurgical clips; * Cochlear implants ; * Neural or peripheral stimulator; * Intra-orbital or encephalic metallic foreign bodies; * Endoprostheses fitted less than 4 weeks ago and osteosynthesis devices fitted less than 6 weeks ago; * Claustrophobia. * Pregnant or breast-feeding women; * Adults under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty. Patients only * Score \>2 on the modified Hachinski scale (Hachinski et al., 2012) * Dementia according to McKhann criteria (McKhann et al., 2011) * Sensory deficit interfering with experimental tests Healthy volunteers only \- Cognitive impairment (MoCA score \< 26)
๐Ÿ’Š

What it tests

  • fMRI
  • CONFMEM
๐Ÿ“

Where

1 site
CHU Rennes
Rennes, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy